Literature DB >> 7591903

Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors.

T W Leung1, W Y Lau, S K Ho, S C Ward, J H Chow, M S Chan, C Metreweli, P J Johnson, A K Li.   

Abstract

PURPOSE: To investigate the clinical, histopathological, and radiological features of radiation pneumonitis arising as a complication of selective internal radiation treatment for liver tumors. To correlate the development of radiation pneumonitis with the degree of lung shunting as assessed by 99mTechnetium-labeled macroaggregated albumin (Tc-MAA) scan. METHODS AND MATERIALS: Five out of 80 patients who had inoperable hepatic tumors and underwent treatment with intraarterial 90Yttrium- (90Y)-microspheres, developed progressive restrictive ventilatory dysfunction without an infective or cardiovascular cause. Histopathological evidence of a pneumonitis and the presence of microspheres in the lung tissue suggested a diagnosis of radiation pneumonitis. The clinical course, radiological and histopathological findings, percentage tumor shunting to the lungs (lung shunting, as predicted by gamma camera scanning after intraarterial Tc-MAA), and the estimated radiation dose to the lungs were analyzed. In an attempt to reduce pulmonary shunting of the microspheres, three patients received partial hepatic embolization with inert particles before selective internal radiation therapy.
RESULTS: In the five patients who developed radiation pneumonitis, lung shunting percentages (as predicted by Tc-MAA scan) ranged from 13.1 to 45.6% (median 23.7%). The estimated whole lung radiation dose ranged from 10.43 Gy to 36.44 Gy (median 25.04 Gy). Among 75 patients who did not develop radiation pneumonitis, the percentage lung shunting ranged from less than 1% to 15% (median 6%). Nine patients had lung shunting greater than 13% and five of them developed radiation pneumonitis, whereas this developed in none of those in whom shunting was below 13%. The onset of radiation pneumonitis ranged from 1 to 6 months after internal radiation treatment. All five patients exhibited characteristic plain radiographic and computerized tomographic changes comprising extensive consolidation with well-defined lateral margins. Clinical improvement after corticosteroid treatment was seen in two patients. Three patients died from respiratory failure and two from other causes. Partial hepatic arterial embolization reduced the degree of lung shunting to less than 13%, but did not prevent the development of radiation pneumonitis.
CONCLUSION: Radiation pneumonitis may become a complication after intraarterial 90Y-microspheres treatment when lung shunting, as assessed by Tc-MAA scan, is high (above 13%). Prescribed activity of 90Y and lung shunting of Tc-MAA should be considered together before giving selective internal radiation (SIR) therapy for hepatic tumors, and preferably avoided if the lung shunting is above 13%.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591903     DOI: 10.1016/0360-3016(95)00039-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  70 in total

Review 1.  Radioembolization for primary and metastatic liver cancer.

Authors:  Khairuddin Memon; Robert J Lewandowski; Laura Kulik; Ahsun Riaz; Mary F Mulcahy; Riad Salem
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with 99mTc-MAA accumulation in the anterior abdominal wall?

Authors:  Hojjat Ahmadzadehfar; Markus Möhlenbruch; Amir Sabet; Carsten Meyer; Marianne Muckle; Torjan Haslerud; Kai Wilhelm; Hans Heinz Schild; Hans Jürgen Biersack; Samer Ezziddin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-15       Impact factor: 9.236

3.  Biliary complications associated with selective internal radiation (SIR) therapy for unresectable liver malignancies.

Authors:  Simon S M Ng; Simon C H Yu; Paul B S Lai; W Y Lau
Journal:  Dig Dis Sci       Date:  2008-03-05       Impact factor: 3.199

4.  Radioembolization of yttrium-90 microspheres for hepatic malignancy.

Authors:  Ravi Murthy; Paresh Kamat; Rodolfo Nuñez; Riad Salem
Journal:  Semin Intervent Radiol       Date:  2008-03       Impact factor: 1.513

Review 5.  Radioembolization of hepatic tumors.

Authors:  Andrew Kennedy
Journal:  J Gastrointest Oncol       Date:  2014-06

6.  [Selective internal radiotherapy (SIRT) of liver tumors].

Authors:  H Duan; M Hoffmann
Journal:  Radiologe       Date:  2015-01       Impact factor: 0.635

Review 7.  Advances in managing hepatocellular carcinoma.

Authors:  Marielle Reataza; David K Imagawa
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

Review 8.  Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives.

Authors:  Cristina Mosconi; Alberta Cappelli; Cinzia Pettinato; Rita Golfieri
Journal:  World J Hepatol       Date:  2015-04-18

9.  Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis.

Authors:  M A D Vente; M Wondergem; I van der Tweel; M A A J van den Bosch; B A Zonnenberg; M G E H Lam; A D van Het Schip; J F W Nijsen
Journal:  Eur Radiol       Date:  2008-11-07       Impact factor: 5.315

10.  A pilot study of trans-arterial injection of 166Holmium-Chitosan complex for treatment of small hepatocellular carcinoma.

Authors:  Byoung Chul Cho; Eun Hee Kim; Hye Jin Choi; Joo Hang Kim; Jae Kyung Roh; Hyun Cheol Chung; Joong Bae Ahn; Jong Doo Lee; Jong Tae Lee; Nae Choon Yoo; Joo Hyuk Sohn
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.